Menu
Back to User profile » Dr Afsaneh Vazin
Papers published by Dr Afsaneh Vazin:
Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen
Mirjalili M, Shafiekhani M, Vazin A
Therapeutics and Clinical Risk Management 2020, 16:617-629
Published Date: 3 July 2020
Major Neurologic Adverse Drug Reactions, Potential Drug–Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review
Ghasemiyeh P, Borhani-Haghighi A, Karimzadeh I, Mohammadi-Samani S, Vazin A, Safari A, Qureshi AI
Therapeutics and Clinical Risk Management 2020, 16:595-605
Published Date: 30 June 2020
Curcumin Supplementation Alleviates Polymyxin E-Induced Nephrotoxicity
Vazin A, Heidari R, Khodami Z
Journal of Experimental Pharmacology 2020, 12:129-136
Published Date: 4 June 2020
Comparison of Ceftizoxime Plus Ampicillin-Sulbactam versus Gentamicin Plus Ampicillin-Sulbactam in the Prevention of Post-Transplant Early Bacterial Infections in Liver Transplant Recipients: A Randomized Controlled Trial
Shafiekhani M, Karimzadeh I, Nikeghbalian S, Firoozifar M, Pouladfar G, Vazin A
Infection and Drug Resistance 2020, 13:89-98
Published Date: 8 January 2020
Prevalence, Risk Factors And Treatment Of The Most Common Gram-Negative Bacterial Infections In Liver Transplant Recipients: A Review
Shafiekhani M, Mirjalili M, Vazin A
Infection and Drug Resistance 2019, 12:3485-3495
Published Date: 13 November 2019
In vitro activity of colistin in combination with various antimicrobials against Acinetobacter baumannii species, a report from South Iran
Kheshti R, Pourabbas B, Mosayebi M, Vazin A
Infection and Drug Resistance 2019, 12:129-135
Published Date: 31 December 2018
Psychotropic drug therapy in patients in the intensive care unit - usage, adverse effects and drug interactions: a review
Shafiekhani M, Mirjalili M, Vazin A
Therapeutics and Clinical Risk Management 2018, 14:1799-1812
Published Date: 28 September 2018